Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Term Elamipretide in Hospitalized Heart Failure with Congestion
2016-000126-19Phase 2Completed
- Sponsor
- Stealth BioTherapeutics
- Start
- Jul 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Elamipretide with Placebo (2 arms). Primary endpoint: Change in NT-proBNP between Baseline and Day 8/Early Discharge. Started Jul 2016; status: completed.
02
Drugs
elamipretide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2016-000126-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000126-19.